Literature DB >> 12959309

A comparison of the acute haemodynamic effects of nisoldipine and nifedipine during treatment with atenolol in patients with coronary artery disease.

K M Donaldson1, K D Dawkins, D G Waller.   

Abstract

1. The acute haemodynamic effects of intravenous nisoldipine (1, 2, 4 microg kg(-1)) and nifedipine (2.5, 5, 10 microg kg(-1)) were compared in a randomised, within-patient crossover study. Fifteen male patients with stable angina pectoris treated with atenolol were studied after undergoing routine cardiac catheterisation. 2. Nisoldipine caused a dose-related fall in systemic vascular resistance (maximum 22%) associated with an increase in heart rate and cardiac index (18%) and a fall in mean arterial pressure (7%). 3. By contrast, nifedipine was associated with a significant increase in heart rate but systemic vascular resistance, cardiac index and mean arterial pressure remained unaltered. 4. At doses with equivalent effects on heart rate (2 microg kg(-1) nisoldipine; 10 microg kg(-1) nifedipine) acute dosing with nisoldipine caused a significantly greater fall in systemic vascular resistance and increase in cardiac index, whilst nifedipine caused a greater reduction in stroke volume index and left ventricular stroke work index. 5. The results suggest that, when combined with atenolol, acute dosing with nisoldipine may have a more complementary haemodynamic profile than nifedipine. The implications of this finding for chronic oral dosing in patients with impaired left ventricular function should be evaluated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 12959309      PMCID: PMC1364684          DOI: 10.1111/j.1365-2125.1993.tb00370.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

1.  [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].

Authors:  W K Raff; F Kosche; W Lochner
Journal:  Arzneimittelforschung       Date:  1972-01

2.  The two-period cross-over clinical trial.

Authors:  M Hills; P Armitage
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

3.  Effect of intravenous and intracoronary nifedipine on coronary blood flow and myocardial oxygen consumption.

Authors:  P Schanzenbächer; G Liebau; P Deeg; K Kochsiek
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

4.  Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function.

Authors:  P A Ludbrook; A J Tiefenbrunn; F R Reed; B E Sobel
Journal:  Circulation       Date:  1982-03       Impact factor: 29.690

5.  Haemodynamic effects of nifedipine in heart failure.

Authors:  S Klugmann; A Salvi; F Camerini
Journal:  Br Heart J       Date:  1980-04

6.  Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease.

Authors:  S Gunther; L Green; J E Muller; G H Mudge; W Grossman
Journal:  Circulation       Date:  1981-04       Impact factor: 29.690

7.  Slow release nifedipine plus atenolol in chronic stable angina pectoris.

Authors:  V F Challenor; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

8.  Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).

Authors:  S Kazda; B Garthoff; H Meyer; K Schlossmann; K Stoepel; R Towart; W Vater; E Wehinger
Journal:  Arzneimittelforschung       Date:  1980

9.  Nifedipine and left ventricular function in beta-blocked patients.

Authors:  P I Joshi; J J Dalal; M S Ruttley; D J Sheridan; A H Henderson
Journal:  Br Heart J       Date:  1981-04

10.  Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.

Authors:  P Lynch; H Dargie; S Krikler; D Krikler
Journal:  Br Med J       Date:  1980-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.